Cell intrinsically, mutant calreticulin promotes megakaryocytic differentiation through MPL activation, which is consistent with the fact that CALR mutations engender MPN with a megakaryocytic lineage phenotype (i.e. ET and PMF).19 The gene discussed is MPL; the disease is myeloproliferative disorder.